PortfoliosLab logoPortfoliosLab logo
HEAE.L vs. BIGT.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

HEAE.L vs. BIGT.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in SPDR MSCI Europe Health Care UCITS ETF (HEAE.L) and L&G Pharma Breakthrough UCITS ETF (BIGT.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

HEAE.L is traded in GBP, while BIGT.L is traded in GBp. To make them comparable, the BIGT.L values have been converted to GBP using the latest available exchange rates.

Returns By Period

In the year-to-date period, HEAE.L achieves a -2.42% return, which is significantly lower than BIGT.L's -0.70% return.


HEAE.L

1D
3.29%
1M
1.82%
YTD
-2.42%
6M
-1.32%
1Y
9.06%
3Y*
2.88%
5Y*
10Y*

BIGT.L

1D
2.65%
1M
-3.25%
YTD
-0.70%
6M
-3.88%
1Y
25.65%
3Y*
2.96%
5Y*
2.49%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

HEAE.L vs. BIGT.L - Yearly Performance Comparison


2026 (YTD)2025202420232022
HEAE.L
SPDR MSCI Europe Health Care UCITS ETF
-2.42%13.38%-1.21%5.53%-5.60%
BIGT.L
L&G Pharma Breakthrough UCITS ETF
-0.70%27.03%-3.16%-14.88%0.72%

Correlation

The correlation between HEAE.L and BIGT.L is 0.60, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.60

Correlation (3Y)
Calculated over the trailing 3-year period

0.50

Correlation (All Time)
Calculated using the full available price history since Apr 11, 2022

0.46

The correlation between HEAE.L and BIGT.L shifts across timeframes, from 0.46 (all time) to 0.60 (1 year), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HEAE.L vs. BIGT.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HEAE.L
HEAE.L Risk / Return Rank: 1818
Overall Rank
HEAE.L Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
HEAE.L Sortino Ratio Rank: 1818
Sortino Ratio Rank
HEAE.L Omega Ratio Rank: 1818
Omega Ratio Rank
HEAE.L Calmar Ratio Rank: 1717
Calmar Ratio Rank
HEAE.L Martin Ratio Rank: 1717
Martin Ratio Rank

BIGT.L
BIGT.L Risk / Return Rank: 4343
Overall Rank
BIGT.L Sharpe Ratio Rank: 4040
Sharpe Ratio Rank
BIGT.L Sortino Ratio Rank: 4141
Sortino Ratio Rank
BIGT.L Omega Ratio Rank: 3737
Omega Ratio Rank
BIGT.L Calmar Ratio Rank: 5353
Calmar Ratio Rank
BIGT.L Martin Ratio Rank: 4545
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HEAE.L vs. BIGT.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR MSCI Europe Health Care UCITS ETF (HEAE.L) and L&G Pharma Breakthrough UCITS ETF (BIGT.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HEAE.LBIGT.LDifference
Sharpe ratioReturn per unit of total volatility

-0.85

Sortino ratioReturn per unit of downside risk

-1.14

Omega ratioGain probability vs. loss probability

1.11

1.24

-0.13

Calmar ratioReturn relative to maximum drawdown

0.66

2.57

-1.91

Martin ratioReturn relative to average drawdown

1.57

7.42

-5.85

HEAE.L vs. BIGT.L - Sharpe Ratio Comparison

The current HEAE.L Sharpe Ratio is 0.54, which is lower than the BIGT.L Sharpe Ratio of 1.39. The chart below compares the historical Sharpe Ratios of HEAE.L and BIGT.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


HEAE.LBIGT.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.54

1.39

-0.85

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.15

Sharpe Ratio (All Time)

Calculated using the full available price history

0.14

0.22

-0.07

Drawdowns

HEAE.L vs. BIGT.L - Drawdown Comparison

The maximum HEAE.L drawdown since its inception was -24.51%, smaller than the maximum BIGT.L drawdown of -30.23%. Use the drawdown chart below to compare losses from any high point for HEAE.L and BIGT.L.


Loading charts...

Drawdown Indicators


HEAE.LBIGT.LDifference

Max Drawdown

Largest peak-to-trough decline

-24.51%

-30.23%

+5.72%

Max Drawdown (1Y)

Largest decline over 1 year

-13.73%

-9.93%

-3.80%

Max Drawdown (3Y)

Largest decline over 3 years

-24.51%

-23.74%

-0.77%

Max Drawdown (5Y)

Largest decline over 5 years

-30.23%

Current Drawdown

Current decline from peak

-10.88%

-5.41%

-5.47%

Average Drawdown

Average peak-to-trough decline

-7.69%

-10.57%

+2.88%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.78%

3.45%

+2.33%

Volatility

HEAE.L vs. BIGT.L - Volatility Comparison

The current volatility for SPDR MSCI Europe Health Care UCITS ETF (HEAE.L) is 5.60%, while L&G Pharma Breakthrough UCITS ETF (BIGT.L) has a volatility of 6.35%. This indicates that HEAE.L experiences smaller price fluctuations and is considered to be less risky than BIGT.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HEAE.LBIGT.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.60%

6.35%

-0.75%

Volatility (6M)

Calculated over the trailing 6-month period

12.12%

14.10%

-1.98%

Volatility (1Y)

Calculated over the trailing 1-year period

16.79%

18.38%

-1.59%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.28%

16.86%

-0.58%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

16.28%

18.38%

-2.10%

HEAE.L vs. BIGT.L - Expense Ratio Comparison

HEAE.L has a 0.18% expense ratio, which is lower than BIGT.L's 0.49% expense ratio.


Dividends

HEAE.L vs. BIGT.L - Dividend Comparison

Neither HEAE.L nor BIGT.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


HEAE.L and BIGT.L have a correlation of 0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, HEAE.L is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.

HEAE.L is cheaper with a 0.18% expense ratio, compared with 0.49% for BIGT.L.

HEAE.L tracks MSCI World/Health Care NR USD, while BIGT.L tracks NASDAQ Biotechnology TR USD. They also come from different issuers: State Street and Legal & General. Their fees differ too: 0.18% for HEAE.L and 0.49% for BIGT.L.

Portfolio Optimizer

Find the right allocation for HEAE.L and BIGT.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer